NCT06785519View on ClinicalTrials.gov

CD19/BCMA CAR-T Cell Therapy for Refractory/Relapsed Lupus Nephritis

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

January 31, 2025

Primary Completion Date

October 31, 2027

Study Completion Date

October 31, 2027

Conditions
Lupus Nephritis
Interventions
BIOLOGICAL

CD19/BCMA Lupus Nephritis Targeted CAR T-cells injection

Each subject receive CD19/BCMA Lupus Nephritis Targeted CAR T-cells by intravenous infusion

Trial Locations (1)

310003

RECRUITING

The first affiliated hospital of medical college of zhejiang university, Hangzhou

All Listed Sponsors
collaborator

Yake Biotechnology Ltd.

INDUSTRY

lead

He Huang

OTHER